Merck’s anti-clotting drug flops in key trial
by on Nov.13, 2011, under Health and Fitness
A blood thinner being developed by Merck has flopped in a major study aimed at preventing heart attacks, strokes and other problems in people who had suffered a heart attack or severe chest pain from clogged arteries.
View full post on Yahoo! Health News
